Insider · CIK 0001595612

Brennan Daniel J.

Reports to the SEC for 4 companies · WEST CONSHOHOCKEN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001595612

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+404 sh	—	—	1,371
2026-06-17	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+681 sh	—	—	681
2026-02-25	WATWATERS CORP /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+57 sh	—	—	57
2026-02-25	WATWATERS CORP /DE/A Award	Director	AAward	+23 sh	—	—	1,355
2026-01-02	WATWATERS CORP /DE/A Award	Director	AAward	+307 sh	—	—	1,332
2026-01-02	WATWATERS CORP /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+828 sh	—	—	828
2025-08-01	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+967 sh	—	—	967
2025-08-01	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,705 sh	—	—	1,705
2025-02-19	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+9,483 sh	$40.12	+$380K	293,141
2025-02-19	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and CFO	SSale	−67.3K sh	$105.24	−$7.09M	225,808
2025-02-19	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CFO	MExercise/Conversion	−9,483 sh	—	—	37,934
2025-02-19	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CFO	MExercise/Conversion	−16.9K sh	—	—	0
2025-02-19	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+15.6K sh	$27.09	+$424K	283,658
2025-02-19	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+18.5K sh	$24.55	+$455K	251,151
2025-02-19	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CFO	MExercise/Conversion	−15.6K sh	—	—	31,285
2025-02-19	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CFO	MExercise/Conversion	−18.5K sh	—	—	37,067
2025-02-19	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+16.9K sh	$17.26	+$291K	268,016
2025-02-18	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and CFO	SSale	−2,900 sh	$104.08	−$302K	247,248
2025-02-18	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and CFO	SSale	−14.6K sh	$104.67	−$1.53M	232,618
2025-02-17	BSXBOSTON SCIENTIFIC CORP · Restricted Stock UnitsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−4,584 sh	—	—	0
2025-02-17	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+4,584 sh	—	—	252,365
2025-02-17	BSXBOSTON SCIENTIFIC CORPF Tax Payment	EVP and CFO	FTax Payment	−2,217 sh	$106.11	−$235K	250,148
2025-02-16	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+4,243 sh	—	—	249,833
2025-02-16	BSXBOSTON SCIENTIFIC CORPF Tax Payment	EVP and CFO	FTax Payment	−2,052 sh	$106.11	−$218K	247,781
2025-02-16	BSXBOSTON SCIENTIFIC CORP · Restricted Stock UnitsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−4,243 sh	—	—	4,243
2025-02-14	BSXBOSTON SCIENTIFIC CORPF Tax Payment	EVP and CFO	FTax Payment	−2,110 sh	$106.11	−$224K	245,590
2025-02-14	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+4,362 sh	—	—	247,700
2025-02-14	BSXBOSTON SCIENTIFIC CORP · Restricted Stock UnitsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−4,362 sh	—	—	8,725
2025-02-13	BSXBOSTON SCIENTIFIC CORP · Restricted Stock UnitsA Award	EVP and CFO	AAward	+8,950 sh	—	—	8,950
2025-02-13	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)A Award	EVP and CFO	AAward	+23K sh	—	—	23,031
2025-02-12	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+15.1K sh	$16.31	+$246K	256,538
2025-02-12	BSXBOSTON SCIENTIFIC CORP · Restricted Stock UnitsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−3,654 sh	—	—	10,963
2025-02-12	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+3,654 sh	—	—	245,105
2025-02-12	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and CFO	SSale	−15.1K sh	$105.07	−$1.59M	241,451
2025-02-12	BSXBOSTON SCIENTIFIC CORPF Tax Payment	EVP and CFO	FTax Payment	−1,767 sh	$105.77	−$187K	243,338
2025-02-12	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CFO	MExercise/Conversion	−15.1K sh	—	—	0
2025-02-11	BSXBOSTON SCIENTIFIC CORPF Tax Payment	EVP and CFO	FTax Payment	−16.4K sh	$105.98	−$1.74M	241,451
2025-02-11	BSXBOSTON SCIENTIFIC CORPA Award	EVP and CFO	AAward	+33.9K sh	—	—	257,865
2025-01-03	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and CFO	SSale	−9,689 sh	$89.86	−$871K	223,921
2025-01-02	WATWATERS CORP /DE/A Award	Director	AAward	+319 sh	—	—	1,025
2025-01-02	WATWATERS CORP /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+818 sh	—	—	818
2025-01-01	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+14.9K sh	—	—	238,822
2025-01-01	BSXBOSTON SCIENTIFIC CORP · Performance Share UnitsM Exercise/Conversion	EVP and CFO	MExercise/Conversion	−14.9K sh	—	—	0
2025-01-01	BSXBOSTON SCIENTIFIC CORPF Tax Payment	EVP and CFO	FTax Payment	−5,212 sh	$89.32	−$466K	233,610
2024-05-23	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and CFO	SSale	−47.6K sh	$75.11	−$3.58M	223,921
2024-05-22	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+15.1K sh	$16.31	+$246K	335,996
2024-05-22	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+15.6K sh	$27.09	+$424K	320,910
2024-05-22	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CFO	MExercise/Conversion	−16.9K sh	—	—	55,600
2024-05-22	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and CFO	MExercise/Conversion	+16.9K sh	$24.55	+$414K	288,405
2024-05-22	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CFO	MExercise/Conversion	−15.6K sh	—	—	46,927

Recent filings

Accepted (ET)
Jun 184
Brennan Daniel J.0001628280-26-044290
SEC(opens sec.gov)
Feb 274
Brennan Daniel J.0001000697-26-000073
SEC(opens sec.gov)
Jan 54
Brennan Daniel J.0001000697-26-000023
SEC(opens sec.gov)
Aug 54
Brennan Daniel J.0001628280-25-038008
SEC(opens sec.gov)
Feb 194
Brennan Daniel J.0001225208-25-001969
SEC(opens sec.gov)
Feb 184
Brennan Daniel J.0001225208-25-001863
SEC(opens sec.gov)

Companies

Address

C/O MADRIGAL PHARMACEUTICALS, INC. 200 BARR HARBOR DRIVE, SUITE 200

WEST CONSHOHOCKEN, PA, 19428